Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genomic Medicine Center of Excellence, |
RCV000171237 | SCV000221434 | likely pathogenic | not provided | criteria provided, single submitter | research | ||
Ocular Genomics Institute, |
RCV001376479 | SCV001573636 | likely pathogenic | Retinitis pigmentosa 37 | 2021-04-08 | criteria provided, single submitter | research | The NR2E3 c.373C>T variant was identified in an individual with retinitis pigmentosa with a presumed recessive inheritance pattern. Through a review of available evidence we were able to apply the following criteria: PVS1, PM2. Based on this evidence we have classified this variant as Likely Pathogenic. |
Labcorp Genetics |
RCV000171237 | SCV002244477 | pathogenic | not provided | 2024-12-19 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg125*) in the NR2E3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in NR2E3 are known to be pathogenic (PMID: 15459973, 27522502). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This premature translational stop signal has been observed in individual(s) with autosomal recessive NR2E3-related conditions (PMID: 23039133, 26355662). ClinVar contains an entry for this variant (Variation ID: 191060). For these reasons, this variant has been classified as Pathogenic. |
Baylor Genetics | RCV003468851 | SCV004191603 | pathogenic | Enhanced S-cone syndrome | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Institute of Human Genetics, |
RCV004815268 | SCV005072147 | pathogenic | Retinal dystrophy | 2012-01-01 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV005003522 | SCV005631020 | pathogenic | Enhanced S-cone syndrome; Retinitis pigmentosa 37 | 2024-02-12 | criteria provided, single submitter | clinical testing |